These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 66035)

  • 21. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
    Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
    J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of cardiac and renal beta-receptors by low dose propranolol in normal subjects. Clues to its antihypertensive effect.
    Davies R; Pickering TG; Morganti A; Wilson M; Laragh JH
    Br Heart J; 1979 Mar; 41(3):331-5. PubMed ID: 34409
    [No Abstract]   [Full Text] [Related]  

  • 23. Beta-blocking potency of mepindolol and pindolol against isoproterenol-induced inotropic and chronotropic responses in guinea pig atria.
    Anderson WG
    J Cardiovasc Pharmacol; 1984; 6(1):7-11. PubMed ID: 6199615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of beta blockade and intrinsic sympathomimetic activity on exercise performance.
    Ades PA; Brammell HL; Greenberg JH; Horwitz LD
    Am J Cardiol; 1984 Dec; 54(10):1337-41. PubMed ID: 6507309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The sympathomimetic activity of (+/-)-pindolol at beta 1- and beta 2-adrenoceptor sites.
    Mian MA; Malta E
    Eur J Pharmacol; 1985 Feb; 109(1):65-71. PubMed ID: 2986991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study on the effects of alprenolol, bunitrolol, ethaverine, oxprenolol, papaverine, practolol, pindolol, pronethalol, propranolol, toliprolol and verapamil on cardiac and bronchial beta-receptors (author's transl)].
    Wuppermann D; Zimmermann F; Friedrich L
    Arzneimittelforschung; 1978; 28(5):794-8. PubMed ID: 35172
    [No Abstract]   [Full Text] [Related]  

  • 27. An application of receptor models to the analysis of data on beta-adrenoceptor blockade.
    Ferguson RA; Robertson HH; Bilski AJ; Wale JL
    Clin Exp Pharmacol Physiol; 1979; 6(1):21-9. PubMed ID: 32982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronotropic cardiac effects of falipamil in conscious dogs: interactions with the autonomic nervous system and various ionic conductances.
    Boucher M; Chassaing C; Chapuy E; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):569-75. PubMed ID: 7516006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of beta-blockade and the non-specific effect of bucumolol, a beta-adrenergic blocking agent, on atrioventricular conduction in anesthetized dogs.
    Nakayama K; Oshima T; Koike H
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):145-56. PubMed ID: 6121536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta 1-selective and non-selective beta-adrenoceptor blockade, anaerobic threshold and respiratory gas exchange during exercise.
    McLeod AA; Knopes KD; Shand DG; Williams RS
    Br J Clin Pharmacol; 1985 Jan; 19(1):13-20. PubMed ID: 2858214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of beta-adrenoceptor subtypes in the dissociation between blockade and stimulation.
    Walter M; Lemoine H; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):159-75. PubMed ID: 6092972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro.
    Minneman KP; Hegstrand LR; Molinoff PB
    Mol Pharmacol; 1979 Jul; 16(1):21-33. PubMed ID: 39243
    [No Abstract]   [Full Text] [Related]  

  • 34. Adenosine antagonizes the positive inotropic action mediated via beta-, but not alpha-adrenoceptors in the rabbit papillary muscle.
    Endoh M; Yamashita S
    Eur J Pharmacol; 1980 Aug; 65(4):445-8. PubMed ID: 6250859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors.
    Weiland GA; Minneman KP; Molinoff PB
    Mol Pharmacol; 1980 Nov; 18(3):341-7. PubMed ID: 6110167
    [No Abstract]   [Full Text] [Related]  

  • 36. Alinidine reduces heart-rate without blockade of beta-adrenoceptors.
    Harron DW; Riddell JG; Shanks RG
    Lancet; 1981 Feb; 1(8216):351-3. PubMed ID: 6109990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors.
    Neve KA; Molinoff PB
    Am J Cardiol; 1986 Apr; 57(12):17F-22F. PubMed ID: 2871741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG
    Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of propranolol, alprenolol, pindolol, and bopindolol on beta 2-adrenoceptor density in human lymphocytes.
    Brodde OE; Wang XL; O'Hara N; Daul A; Schiess W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S70-3. PubMed ID: 2439825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.